Stock Screener App

Frei -

Installieren

84.52

1.32% 1.10

Oruka Therapeutics Inc (ORKA)

Überblick Nachrichten Preisverlauf Forum Prognose

Oruka Therapeutics Inc Aktie (ORKA) Neueste Nachrichten

Form 144 Oruka Therapeutics For: 1 October By Investing.com - Investing.com Canada

25,000 shares from a stock-option exercise are proposed for sale at Oruka Therapeutics (NASDAQ: ORKA). - Stock Titan

ETFs Investing in Oruka Therapeutics, Inc. Stocks - TradingView

Average basic shares outstanding of Oruka Therapeutics, Inc. – HAN:HQ1 - TradingView

HQ1 Forecast — Price Target — Prediction for 2027 - TradingView

Form 144 Oruka Therapeutics For: 27 September By Investing.com - Investing.com South Africa

Oruka Therapeutics, Inc. (ORKA) stock price, news, quote and history - Yahoo Finance Singapore

Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says - Yahoo Finance

Oruka Therapeutics, Inc. (ORKA) Stock Price, News, Quote & History - Yahoo! Finance Canada

ORKA Stock Down 5% Despite Positive Week 28 Psoriasis Efficacy Data - Yahoo Finance

A Quick Look at Today's Ratings for Oruka Therapeutics(ORKA.US), With a Forecast Between $120 to $175 - Moomoo

Oruka Therapeutics stock price target maintained at $120 by H.C. Wainwright - Investing.com Canada

Oruka Therapeutics stock falls despite positive trial data - Investing.com

Clear Street Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $131 - Moomoo

What Oruka Therapeutics (ORKA)'s Phase 2a Psoriasis Data Means For Shareholders - Yahoo Finance

ORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94% - Stocktwits

Oruka Shares Fall Despite Deepening Week 28 Responses for ORKA-001 - marketscreener.com

Update: Oruka Shares Fall Despite Deepening Week 28 Responses for ORKA-001 - Yahoo Finance

10 Health Care Stocks Whale Activity In Today’s Session - Benzinga

Oruka posts trial data for plaque psoriasis drug (ORKA:NASDAQ) - Seeking Alpha

Oruka Therapeutics Says Psoriasis Drug Shows Deepening Efficacy - AOL.com

Why is Oruka Therapeutics stock sliding today? By Investing.com - Investing.com Canada

Oruka Therapeutics Reports Deepening Responses for ORKA-001 Through Week 28 - marketscreener.com

Oruka Therapeutics Shares Fall 5% After Week 28 ORKA-001 Trial Data - Yahoo Finance

Oruka Therapeutics stock falls despite positive trial data By Investing.com - Investing.com Australia

Oruka reports week 28 psoriasis trial results for ORKA-001 By Investing.com - Investing.com Canada

Oruka reports week 28 psoriasis trial results for ORKA-001 - Investing.com

In a psoriasis trial, 71% had clear skin six months after their last dose - Stock Titan

Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - Investing.com Nigeria

Form 4 Oruka Therapeutics Inc For: 22 September By Investing.com - Investing.com Canada

Form 4 Oruka Therapeutics Inc For: 22 September - Investing.com UK

Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock By Investing.com - Investing.com Australia

Details on Warrant Exercise and Subsequent Share Sales by Oruka Therapeutics' General Counsel - Kalkine Media

Oruka Therapeutics SVP Arjun Agarwal Sells 533 Shares Under Rule 10b5-1 Plan - Kalkine Media

Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock - Investing.com

Oruka Therapeutics Insider Sold Shares Worth $936,417, According to a Recent SEC Filing - marketscreener.com

Oruka Therapeutics (NASDAQ: ORKA) insider plans new share sale after recent 10b5-1 trades - Stock Titan

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A 58.6% Potential Upside Beckons Biotech Investors - DirectorsTalk Interviews

LifeSci Capital Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $175 - Moomoo

Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033 - PR Newswire

Oruka Therapeutics COO Sandler sells $86,713 in common stock By Investing.com - Investing.com South Africa

Oruka Therapeutics chief medical officer Joana Goncalves sells $734k in shares By Investing.com - Investing.com South Africa

Oruka Therapeutics SVP Agarwal sells over $926k in common stock By Investing.com - Investing.com South Africa

Oruka Therapeutics SVP Agarwal sells over $926k in common stock - Investing.com Canada

Oruka Therapeutics CEO Lawrence Klein sells $234,680 in ORKA stock - Investing.com

Oruka Therapeutics chief medical officer Joana Goncalves sells $734k in shares - Investing.com UK

Oruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock By Investing.com - Investing.com Canada

Oruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock - Investing.com UK

Oruka Therapeutics COO Sandler sells $86,713 in common stock - Investing.com

Oruka Therapeutics CEO Lawrence Klein Executes 2,452-Share Sale for RSU Tax Withholding - Kalkine Media

Oruka Therapeutics SVP Finance Arjun Agarwal Reports Multiple Stock Option Exercises and Sales - Kalkine Media

Oruka Therapeutics to Attend Morgan Stanley Global Healthcare Conference - Bitget

BNTX

$96.90

0.05%

RPRX

$57.16

0.82%

ROIV

$35.72

0.62%

ALNY

$219.72

4.96%

ONC

$358.07

0.20%

RVMD

$206.64

0.36%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters